Twist Bioscience stock drops 2.69% as smart drug shrinks tumours by 30%, Twist Bioscience reports

Traders Union
All News
Companies
Twist Bioscience drops 2.69% today

Highlights

TWST remains in an established uptrend, currently trading above key short-, medium-, and long-term moving averages.
Indicators signal bullish momentum is moderating as overbought readings and profit-taking drive recent price pullback.
TWST is expected to consolidate between $66.00 and $72.00 this week, with downside risk limited by strong support levels.

Upward bias sustained as price holds above multi-timeframe supports

TWST is trading at $68.17, above the MA-20 ($62.17), MA-50 ($58.23), and MA-200 ($41.37), which indicates that the price remains in an upward structure across short, medium, and long-term trends. The Ichimoku Kijun is at $64.27, currently acting as immediate support, while near-term support is set by the MA-20 ($62.17) and key support by the MA-50 ($58.23); near-term resistance is found at the MA-10 ($69.37) and key resistance at the MA-5 ($71.12).

Profit-taking triggers pullback as bullish momentum shows early fatigue

MACD and ADX on D1 both point to ongoing bullish momentum, though HMA signals strong sell, suggesting short-term trend exhaustion. RSI and CCI indicate continued buying interest but BBP (Bull/Bear Power) is overbought at 5.99, signaling buyer dominance may be stretched and a potential for a pullback. Stoch RSI is neutral on D1 while being overbought on the weekly view, underscoring mixed momentum. In today's session, TWST has declined 2.69% as profit-taking weighs on price. Over the past week, the stock has slipped $1.05 (1.37%) from a previous close of $69.22. The price is now positioned at the very bottom of the weekly range, and weekly volatility stands at 21.18%. The tone for the week has been a steady retreat from the recent high, reflecting pressure after a period of strong gains.

Consolidation likely as technical signals favor stabilization over breakdown

For the upcoming week, the expected trading range is $66.00 to $72.00, adjusted to reflect the current price and recent weekly volatility. This keeps TWST well above its 52-week low of $23.30 but below the 52-week high of $80.50, anchoring it in the upper half of its yearly range. Based on W1 signals (RSI, ADX, MACD, and MA-50), there is a very high probability (more than 80%) of price stabilization or a move higher next week, with the likelihood of a meaningful decline being very low. The baseline scenario sees TWST consolidating between $66.00 and $72.00 as momentum resets after recent gains. A bullish move could develop if price clears $72.00, potentially re-testing higher resistance levels, while a break below $66.00 would open scope for a pullback towards the MA-20 and MA-50 support zone.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Twist Bioscience was exhibiting sustained bullish momentum, supported by positive trend indicators despite intermittent volatility. This article evaluates how recent developments may influence the prevailing outlook, and traders are advised to monitor for confirmation of a continued upward trajectory or the emergence of a reversal signal.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.